A detailed history of Minot Wealth Management LLC transactions in Aridis Pharmaceuticals, Inc. stock. As of the latest transaction made, Minot Wealth Management LLC holds 50,000 shares of ARDS stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$0
Previous $88,000 37.5%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

BUY
$1.33 - $2.59 $66,500 - $129,500
50,000 New
50,000 $88,000
Q4 2021

Jan 20, 2022

SELL
$2.0 - $3.65 $50,000 - $91,250
-25,000 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$5.3 - $7.4 $250,319 - $349,502
-47,230 Reduced 65.39%
25,000 $152,000
Q1 2021

Apr 29, 2021

SELL
$5.54 - $8.1 $332,693 - $486,429
-60,053 Reduced 45.4%
72,230 $426,000
Q4 2020

Jan 28, 2021

BUY
$6.07 - $8.01 $802,957 - $1.06 Million
132,283 New
132,283 $803,000

Others Institutions Holding ARDS

# of Institutions
2
Shares Held
50.2K
Call Options Held
0
Put Options Held
0

About Aridis Pharmaceuticals, Inc.


  • Ticker ARDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,701,600
  • Description
  • Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...
More about ARDS
Track This Portfolio

Track Minot Wealth Management LLC Portfolio

Follow Minot Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Minot Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Minot Wealth Management LLC with notifications on news.